Meropenem/colistin synergy testing for multidrug-resistant Acinetobacter baumannii strains by a two-dimensional gradient technique applicable in routine microbiology
Author(s) -
Alex van Belkum,
Diane Halimi,
Eve J. Bonetti,
Gesuèle Renzi,
Abdessalam Cherkaoui,
Véronique Sauvonnet,
Rolland Martelin,
G. Durand,
Sonia Chatellier,
Gilles Zambardi,
A. Engelhardt,
Åsa Karlsson,
Jacques Schrenzel
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku342
Subject(s) - acinetobacter baumannii , meropenem , colistin , microbiology and biotechnology , antimicrobial , biology , antibiotics , medicine , antibiotic resistance , bacteria , pseudomonas aeruginosa , genetics
Precise assessment of potential therapeutic synergy, antagonism or indifference between antimicrobial agents currently depends on time-consuming and hard-to-standardize in vitro chequerboard titration methods. We here present a method based on a novel two-dimensional antibiotic gradient technique named Xact™.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom